Advertisement

Topics

Magenta Medical Inc. Company Profile

15:00 EST 13th November 2018 | BioPortfolio


News Articles [140 Associated News Articles listed on BioPortfolio]

STAT Plus: Magenta’s stem cell expansion therapy reveals hope and concern in first data look

By expanding the number of stem cells in each cord blood unit, Magenta aims to give more patients a chance at a successful transplant.

Initial public offering nets $93mm for Magenta Therapeutics

Magenta Therapeutics Inc. (curative stem cell transplantation) netted $93mm through its initial public offering of 6.67mm common shares at $15, the midpoint of its anticipated range.

Magenta Therapeutics Sets Sights on $100 Million IPO To Advance Bone Marrow Transplant Programs

Weeks after securing $52 million in a Series C financing, Magenta Therapeutics is eying the raising of $100 million in an initial public offering two years after it was launched by Third Rock Ventures...

Magenta’s Bastiano Sanna Appointed Semma Therapeutics CEO

Bastiano Sanna has been named CEO and president of Semma Therapeutics. Elizabeth Stoner, who has been serving as interim CEO, will remain as an advisor to the company. Sanna comes to Cambridge, MA-bas...

Magenta Therapeutics to Present at Wedbush PacGrow Healthcare Conference

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patient...

A Closer Look: Magenta Therapeutics IPO

Magenta Therapeutics: This June IPO Should Be On Your Radar

Magenta Therapeutics Readies $100 IPO Plans

Drugs and Medications [0 Results]

None

PubMed Articles [1729 Associated PubMed Articles listed on BioPortfolio]

Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015.

The Canadian federal government has committed to legalizing non-medical cannabis use by adults in 2018. Medical use was legalized in 2001; however, not all people reporting medical use have medical au...

Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization.

Marijuana use is clinically problematic in depression, and non-medical and medical use may both contribute to barriers to care in this population. Among outpatients with depression, we examined the di...

Insights into medical humanities education in China and the West.

Medical humanity is the soul of health education. Beginning medical students are taught various aspects of basic medicine, such as biochemistry, anatomy, and immunology. However, cultivation of the hu...

Medical Marijuana Users are More Likely to Use Prescription Drugs Medically and Nonmedically.

Previous studies have found a negative population-level correlation between medical marijuana availability in US states, and trends in medical and nonmedical prescription drug use. These studies have ...

Should parents see their teen's medical record? Asking about the effect on adolescent-doctor communication changes attitudes.

Parents routinely access young children's medical records, but medical societies strongly recommend confidential care during adolescence, and most medical centers restrict parental records access duri...

Clinical Trials [1720 Associated Clinical Trials listed on BioPortfolio]

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

The goal of this research study is to test the effects of online genetic education alone or in combination with telephone genetic counseling in order to compare the two methods and the str...

A 24-52-Week Study to Evaluate the Long-Term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)

The purpose of the study is to evaluate the long-term efficacy and safety of saredutant in patients with depression. The primary objective is to evaluate the efficacy and safety of saredut...

Doctor-Parent Interactions With Medical Scribes

The purpose of the study is to collect outcomes related to a quality improvement project assessing the feasibility and effectiveness of a medical scribe program in which medical scribes ac...

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or non...

Chart Review Study of Medical Abortion

The primary objective of this study is to document the rates of success and serious complications among women having outpatient medical abortions with 200 mg mifepristone + 800 buccal miso...

Companies [1210 Associated Companies listed on BioPortfolio]

Magenta Therapeutics

Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based dise...

Magenta Therapeutics Inc.

Magenta Therapeutics is a biotechnology company developing therapeutics to revolutionize bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic di...

Magenta Medical Inc.

Magenta Therapeutics, Inc.

Chemence Medical, Inc.

Chemence Medical, Inc., headquartered in metropolitan Atlanta, GA, has redefined the medical adhesives industry, and has become a world leader in the medical device arena since it...

More Information about "Magenta Medical Inc." on BioPortfolio

We have published hundreds of Magenta Medical Inc. news stories on BioPortfolio along with dozens of Magenta Medical Inc. Clinical Trials and PubMed Articles about Magenta Medical Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Magenta Medical Inc. Companies in our database. You can also find out about relevant Magenta Medical Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record